Apurano Pharmaceuticals GmbH
Quick facts
Phase 3 pipeline
- Adezunap · Other
- Adezunap (AP707) · Immunology
Adezunap is a small-molecule inhibitor of adenosine deaminase that increases intracellular adenosine and deoxyadenosine levels to promote immune cell apoptosis and reduce inflammation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: